IMMEDIATE IMMUNITY Trademark

Trademark Overview


On Friday, March 7, 2003, a trademark application was filed for IMMEDIATE IMMUNITY with the United States Patent and Trademark Office. The USPTO has given the IMMEDIATE IMMUNITY trademark a serial number of 78223167. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, May 18, 2004. This trademark is owned by XENEREX BIOSCIENCES. The IMMEDIATE IMMUNITY trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:

Biochemicals, namely, monoclonal antibodies and fragments thereof, for research, development and manufacturing of pharmaceuticals; cell lines for use in the manufacture of pharmaceuticals; biochemical products for use in the development of vaccines, namely therapeutic vaccines, polypeptide, viral and nucleic acids vaccines, antibodies, polypeptides, protein and nucleic acids for vaccine use; and vaccine excipients, vaccine carriers, and vaccine adjuvants for medical science

Biochemicals, namely, monoclonal antibodies and fragments thereof, for clinical, diagnostic and therapeutic use for the treatment or prevention of infectious diseases, biowarfare exposure, inflammatory diseases, immune diseases, and genetic diseases; cell lines for clinical, diagnostic and therapeutic use for the treatment or prevention of infectious diseases, biowarfare exposure, inflammatory diseases, immune diseases, and genetic diseases; vaccines, namely, therapeutic vaccines, polypeptide vaccines, live vaccines, viral vaccines, nucleic acid vaccines, vaccines containing antibodies, polypeptides, protein and nucleic acids, vaccine recipients, vaccine carriers, and vaccines adjuvants

Scientific, pharmaceutical and biological product development consultation, namely development consultation for vaccines and vaccine-related products; pharmaceutical and biological product development for others; vaccine and immunotherapy research and development; pharmaceutical, biomedical and biotechnological development of therapeutic vaccines and antibody-based products

General Information


Serial Number78223167
Word MarkIMMEDIATE IMMUNITY
Filing DateFriday, March 7, 2003
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateTuesday, May 18, 2004
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesBiochemicals, namely, monoclonal antibodies and fragments thereof, for research, development and manufacturing of pharmaceuticals; cell lines for use in the manufacture of pharmaceuticals; biochemical products for use in the development of vaccines, namely therapeutic vaccines, polypeptide, viral and nucleic acids vaccines, antibodies, polypeptides, protein and nucleic acids for vaccine use; and vaccine excipients, vaccine carriers, and vaccine adjuvants for medical science
Goods and ServicesBiochemicals, namely, monoclonal antibodies and fragments thereof, for clinical, diagnostic and therapeutic use for the treatment or prevention of infectious diseases, biowarfare exposure, inflammatory diseases, immune diseases, and genetic diseases; cell lines for clinical, diagnostic and therapeutic use for the treatment or prevention of infectious diseases, biowarfare exposure, inflammatory diseases, immune diseases, and genetic diseases; vaccines, namely, therapeutic vaccines, polypeptide vaccines, live vaccines, viral vaccines, nucleic acid vaccines, vaccines containing antibodies, polypeptides, protein and nucleic acids, vaccine recipients, vaccine carriers, and vaccines adjuvants
Goods and ServicesScientific, pharmaceutical and biological product development consultation, namely development consultation for vaccines and vaccine-related products; pharmaceutical and biological product development for others; vaccine and immunotherapy research and development; pharmaceutical, biomedical and biotechnological development of therapeutic vaccines and antibody-based products

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateFriday, April 4, 2003
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, April 4, 2003
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, April 4, 2003
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameXENEREX BIOSCIENCES
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSAN DIEGO, CA 92121

Trademark Events


Event DateEvent Description
Tuesday, May 18, 2004ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Thursday, September 4, 2003NON-FINAL ACTION E-MAILED
Wednesday, August 27, 2003ASSIGNED TO EXAMINER